APO Research
Talk to an analyst

APO RESEARCH · REPORT

NAD+ Booster Capsule

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global NAD+ Booster Capsule Market Outlook and Growth Opportunities 2026

29 December 2025199 pages

Choose your research edition.

Industry ResearchNAD+ Booster Capsule Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal NAD+ Booster Capsule Industry Growth and Trends Forecast to 2032105 pages · $3,450 USDMarket StructureGlobal NAD+ Booster Capsule Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal NAD+ Booster Capsule Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal NAD+ Booster Capsule Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global NAD+ Booster Capsule market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for NAD+ Booster Capsule is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for NAD+ Booster Capsule is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for NAD+ Booster Capsule is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the NAD+ Booster Capsule market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the NAD+ Booster Capsule market include EffePharm, Kingdomway, GeneHarbor, Bontac, NOMON Co., Ltd. (Teijin), Mirailab Bioscience Inc. (Shinkowa Pharmaceutical), Maac10 Formulas, Herbalmax and Genex Formulas, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global NAD+ Booster Capsule market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of NAD+ Booster Capsule and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents NAD+ Booster Capsule sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the NAD+ Booster Capsule market size, projected growth trends, production technologies, key applications, and end-use industries.

NAD+ Booster Capsule Segment by Company

EffePharm

Kingdomway

GeneHarbor

Bontac

NOMON Co., Ltd. (Teijin)

Mirailab Bioscience Inc. (Shinkowa Pharmaceutical)

Maac10 Formulas

Herbalmax

Genex Formulas

EZZ

Elysium Health

Chromadex

CELFULL

NAD+ Booster Capsule Segment by Type

Content ＜98%

Content ≥98%

NAD+ Booster Capsule Segment by Application

Health Care Products

Beauty Products

Others

NAD+ Booster Capsule Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global NAD+ Booster Capsule status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions NAD+ Booster Capsule market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify NAD+ Booster Capsule significant trends, drivers, influence factors in global and regions.

6. To analyze NAD+ Booster Capsule competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global NAD+ Booster Capsule market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of NAD+ Booster Capsule and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of NAD+ Booster Capsule.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the NAD+ Booster Capsule market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global NAD+ Booster Capsule industry.

Chapter 3: Detailed analysis of NAD+ Booster Capsule manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of NAD+ Booster Capsule in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of NAD+ Booster Capsule in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. NAD+ Booster Capsule Industry Trends Table 2. NAD+ Booster Capsule Industry Drivers Table 3. NAD+ Booster Capsule Industry Opportunities and Challenges Table 4. NAD+ Booster Capsule Industry Restraints Table 5. Global NAD+ Booster Capsule Revenue by Company (US$ Million) & (2021-2026) Table 6. Global NAD+ Booster Capsule Revenue Share by Company (2021-2026) Table 7. Global NAD+ Booster Capsule Sales Volume by Company (K Units) & (2021-2026) Table 8. Global NAD+ Booster Capsule Sales Volume Share by Company (2021-2026) Table 9. Global NAD+ Booster Capsule Average Price (US$/Unit) of Company (2021-2026) Table 10. Global NAD+ Booster Capsule Company Ranking, (2024-2026) & (USD Million) Table 11. Global NAD+ Booster Capsule Key Company Manufacturing Base & Headquarters Table 12. Global NAD+ Booster Capsule Company, Product Type & Application Table 13. Global NAD+ Booster Capsule Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global NAD+ Booster Capsule by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Content ＜98% Table 18. Significant Companies of Content ≥98% Table 19. Global NAD+ Booster Capsule Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global NAD+ Booster Capsule Sales Volume by Type (2021-2026) & (K Units) Table 21. Global NAD+ Booster Capsule Sales Volume by Type (2027-2032) & (K Units) Table 22. Global NAD+ Booster Capsule Sales Volume Share by Type (2021-2026) Table 23. Global NAD+ Booster Capsule Sales Volume Share by Type (2027-2032) Table 24. Global NAD+ Booster Capsule Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global NAD+ Booster Capsule Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global NAD+ Booster Capsule Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global NAD+ Booster Capsule Sales Value Share by Type (2021-2026) Table 28. Global NAD+ Booster Capsule Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Health Care Products Table 30. Significant Companies of Beauty Products Table 31. Significant Companies of Others Table 32. Global NAD+ Booster Capsule Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global NAD+ Booster Capsule Sales Volume by Application (2021-2026) & (K Units) Table 34. Global NAD+ Booster Capsule Sales Volume by Application (2027-2032) & (K Units) Table 35. Global NAD+ Booster Capsule Sales Volume Share by Application (2021-2026) Table 36. Global NAD+ Booster Capsule Sales Volume Share by Application (2027-2032) Table 37. Global NAD+ Booster Capsule Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global NAD+ Booster Capsule Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global NAD+ Booster Capsule Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global NAD+ Booster Capsule Sales Value Share by Application (2021-2026) Table 41. Global NAD+ Booster Capsule Sales Value Share by Application (2027-2032) Table 42. Global NAD+ Booster Capsule Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global NAD+ Booster Capsule Sales by Region (2021-2026) & (K Units) Table 44. Global NAD+ Booster Capsule Sales Market Share by Region (2021-2026) Table 45. Global NAD+ Booster Capsule Sales by Region (2027-2032) & (K Units) Table 46. Global NAD+ Booster Capsule Sales Market Share by Region (2027-2032) Table 47. Global NAD+ Booster Capsule Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global NAD+ Booster Capsule Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global NAD+ Booster Capsule Sales Value Share by Region (2021-2026) Table 50. Global NAD+ Booster Capsule Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global NAD+ Booster Capsule Sales Value Share by Region (2027-2032) Table 52. Global NAD+ Booster Capsule Market Average Price (US$/Unit) by Region (2021-2026) Table 53. Global NAD+ Booster Capsule Market Average Price (US$/Unit) by Region (2027-2032) Table 54. Global NAD+ Booster Capsule Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Global NAD+ Booster Capsule Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global NAD+ Booster Capsule Sales by Country (2021-2026) & (K Units) Table 57. Global NAD+ Booster Capsule Sales Market Share by Country (2021-2026) Table 58. Global NAD+ Booster Capsule Sales by Country (2027-2032) & (K Units) Table 59. Global NAD+ Booster Capsule Sales Market Share by Country (2027-2032) Table 60. Global NAD+ Booster Capsule Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global NAD+ Booster Capsule Sales Value Market Share by Country (2021-2026) Table 62. Global NAD+ Booster Capsule Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global NAD+ Booster Capsule Sales Value Market Share by Country (2027-2032) Table 64. EffePharm Company Information Table 65. EffePharm Business Overview Table 66. EffePharm NAD+ Booster Capsule Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. EffePharm NAD+ Booster Capsule Product Portfolio Table 68. EffePharm Recent Development Table 69. Kingdomway Company Information Table 70. Kingdomway Business Overview Table 71. Kingdomway NAD+ Booster Capsule Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. Kingdomway NAD+ Booster Capsule Product Portfolio Table 73. Kingdomway Recent Development Table 74. GeneHarbor Company Information Table 75. GeneHarbor Business Overview Table 76. GeneHarbor NAD+ Booster Capsule Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. GeneHarbor NAD+ Booster Capsule Product Portfolio Table 78. GeneHarbor Recent Development Table 79. Bontac Company Information Table 80. Bontac Business Overview Table 81. Bontac NAD+ Booster Capsule Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Bontac NAD+ Booster Capsule Product Portfolio Table 83. Bontac Recent Development Table 84. NOMON Co., Ltd. (Teijin) Company Information Table 85. NOMON Co., Ltd. (Teijin) Business Overview Table 86. NOMON Co., Ltd. (Teijin) NAD+ Booster Capsule Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. NOMON Co., Ltd. (Teijin) NAD+ Booster Capsule Product Portfolio Table 88. NOMON Co., Ltd. (Teijin) Recent Development Table 89. Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) Company Information Table 90. Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) Business Overview Table 91. Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) NAD+ Booster Capsule Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) NAD+ Booster Capsule Product Portfolio Table 93. Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) Recent Development Table 94. Maac10 Formulas Company Information Table 95. Maac10 Formulas Business Overview Table 96. Maac10 Formulas NAD+ Booster Capsule Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Maac10 Formulas NAD+ Booster Capsule Product Portfolio Table 98. Maac10 Formulas Recent Development Table 99. Herbalmax Company Information Table 100. Herbalmax Business Overview Table 101. Herbalmax NAD+ Booster Capsule Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Herbalmax NAD+ Booster Capsule Product Portfolio Table 103. Herbalmax Recent Development Table 104. Genex Formulas Company Information Table 105. Genex Formulas Business Overview Table 106. Genex Formulas NAD+ Booster Capsule Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. Genex Formulas NAD+ Booster Capsule Product Portfolio Table 108. Genex Formulas Recent Development Table 109. EZZ Company Information Table 110. EZZ Business Overview Table 111. EZZ NAD+ Booster Capsule Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 112. EZZ NAD+ Booster Capsule Product Portfolio Table 113. EZZ Recent Development Table 114. Elysium Health Company Information Table 115. Elysium Health Business Overview Table 116. Elysium Health NAD+ Booster Capsule Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 117. Elysium Health NAD+ Booster Capsule Product Portfolio Table 118. Elysium Health Recent Development Table 119. Chromadex Company Information Table 120. Chromadex Business Overview Table 121. Chromadex NAD+ Booster Capsule Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 122. Chromadex NAD+ Booster Capsule Product Portfolio Table 123. Chromadex Recent Development Table 124. CELFULL Company Information Table 125. CELFULL Business Overview Table 126. CELFULL NAD+ Booster Capsule Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 127. CELFULL NAD+ Booster Capsule Product Portfolio Table 128. CELFULL Recent Development Table 129. Key Raw Materials Table 130. Raw Materials Key Suppliers Table 131. NAD+ Booster Capsule Distributors List Table 132. NAD+ Booster Capsule Customers List Table 133. Research Programs/Design for This Report Table 134. Authors List of This Report Table 135. Secondary Sources Table 136. Primary Sources List of Figures Figure 1. NAD+ Booster Capsule Product Image Figure 2. Global NAD+ Booster Capsule Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global NAD+ Booster Capsule Sales Value (2021-2032) & (US$ Million) Figure 4. Global NAD+ Booster Capsule Sales (2021-2032) & (K Units) Figure 5. Global NAD+ Booster Capsule Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global NAD+ Booster Capsule Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Content ＜98% Image Figure 10. Content ≥98% Image Figure 11. Global NAD+ Booster Capsule Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global NAD+ Booster Capsule Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global NAD+ Booster Capsule Sales Volume Share by Type (2021-2032) Figure 14. Global NAD+ Booster Capsule Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global NAD+ Booster Capsule Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global NAD+ Booster Capsule Sales Value Share by Type (2021-2032) Figure 17. Health Care Products Image Figure 18. Beauty Products Image Figure 19. Others Image Figure 20. Global NAD+ Booster Capsule Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global NAD+ Booster Capsule Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global NAD+ Booster Capsule Sales Volume Share by Application (2021-2032) Figure 23. Global NAD+ Booster Capsule Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global NAD+ Booster Capsule Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global NAD+ Booster Capsule Sales Value Share by Application (2021-2032) Figure 26. Global NAD+ Booster Capsule Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 27. Global NAD+ Booster Capsule Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global NAD+ Booster Capsule Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global NAD+ Booster Capsule Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America NAD+ Booster Capsule Sales Value (2021-2032) & (US$ Million) Figure 31. North America NAD+ Booster Capsule Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe NAD+ Booster Capsule Sales Value (2021-2032) & (US$ Million) Figure 33. Europe NAD+ Booster Capsule Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific NAD+ Booster Capsule Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific NAD+ Booster Capsule Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America NAD+ Booster Capsule Sales Value (2021-2032) & (US$ Million) Figure 37. South America NAD+ Booster Capsule Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa NAD+ Booster Capsule Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa NAD+ Booster Capsule Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA NAD+ Booster Capsule Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA NAD+ Booster Capsule Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA NAD+ Booster Capsule Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada NAD+ Booster Capsule Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada NAD+ Booster Capsule Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada NAD+ Booster Capsule Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico NAD+ Booster Capsule Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico NAD+ Booster Capsule Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico NAD+ Booster Capsule Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany NAD+ Booster Capsule Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany NAD+ Booster Capsule Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany NAD+ Booster Capsule Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France NAD+ Booster Capsule Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France NAD+ Booster Capsule Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France NAD+ Booster Capsule Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. NAD+ Booster Capsule Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. NAD+ Booster Capsule Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. NAD+ Booster Capsule Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy NAD+ Booster Capsule Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy NAD+ Booster Capsule Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy NAD+ Booster Capsule Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain NAD+ Booster Capsule Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain NAD+ Booster Capsule Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain NAD+ Booster Capsule Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia NAD+ Booster Capsule Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia NAD+ Booster Capsule Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia NAD+ Booster Capsule Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands NAD+ Booster Capsule Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands NAD+ Booster Capsule Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands NAD+ Booster Capsule Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries NAD+ Booster Capsule Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries NAD+ Booster Capsule Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries NAD+ Booster Capsule Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China NAD+ Booster Capsule Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China NAD+ Booster Capsule Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China NAD+ Booster Capsule Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan NAD+ Booster Capsule Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan NAD+ Booster Capsule Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan NAD+ Booster Capsule Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea NAD+ Booster Capsule Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea NAD+ Booster Capsule Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea NAD+ Booster Capsule Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India NAD+ Booster Capsule Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India NAD+ Booster Capsule Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India NAD+ Booster Capsule Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia NAD+ Booster Capsule Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia NAD+ Booster Capsule Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia NAD+ Booster Capsule Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia NAD+ Booster Capsule Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia NAD+ Booster Capsule Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia NAD+ Booster Capsule Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil NAD+ Booster Capsule Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil NAD+ Booster Capsule Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil NAD+ Booster Capsule Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina NAD+ Booster Capsule Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina NAD+ Booster Capsule Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina NAD+ Booster Capsule Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile NAD+ Booster Capsule Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile NAD+ Booster Capsule Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile NAD+ Booster Capsule Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia NAD+ Booster Capsule Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia NAD+ Booster Capsule Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia NAD+ Booster Capsule Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru NAD+ Booster Capsule Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru NAD+ Booster Capsule Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru NAD+ Booster Capsule Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia NAD+ Booster Capsule Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia NAD+ Booster Capsule Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia NAD+ Booster Capsule Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel NAD+ Booster Capsule Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia NAD+ Booster Capsule Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia NAD+ Booster Capsule Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE NAD+ Booster Capsule Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE NAD+ Booster Capsule Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE NAD+ Booster Capsule Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey NAD+ Booster Capsule Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey NAD+ Booster Capsule Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey NAD+ Booster Capsule Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran NAD+ Booster Capsule Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran NAD+ Booster Capsule Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran NAD+ Booster Capsule Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt NAD+ Booster Capsule Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt NAD+ Booster Capsule Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt NAD+ Booster Capsule Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. NAD+ Booster Capsule Value Chain Figure 125. Manufacturing Cost Structure Figure 126. NAD+ Booster Capsule Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Content ＜98%
  • Content ≥98%
Applications
  • Health Care Products
  • Beauty Products
  • Others
Companies covered
  • EffePharm
  • Kingdomway
  • GeneHarbor
  • Bontac
  • NOMON Co., Ltd. (Teijin)
  • Mirailab Bioscience Inc. (Shinkowa Pharmaceutical)
  • Maac10 Formulas
  • Herbalmax
  • Genex Formulas
  • EZZ
  • Elysium Health
  • Chromadex
  • CELFULL

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global NAD+ Booster Capsule Sales Value (2021-2032)
  4. 1.2.2 Global NAD+ Booster Capsule Sales Volume (2021-2032)
  5. 1.2.3 Global NAD+ Booster Capsule Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 NAD+ Booster Capsule Market Dynamics
  1. 2.1 NAD+ Booster Capsule Industry Trends
  2. 2.2 NAD+ Booster Capsule Industry Drivers
  3. 2.3 NAD+ Booster Capsule Industry Opportunities and Challenges
  4. 2.4 NAD+ Booster Capsule Industry Restraints
3 NAD+ Booster Capsule Market by Company
  1. 3.1 Global NAD+ Booster Capsule Company Revenue Ranking in 2025
  2. 3.2 Global NAD+ Booster Capsule Revenue by Company (2021-2026)
  3. 3.3 Global NAD+ Booster Capsule Sales Volume by Company (2021-2026)
  4. 3.4 Global NAD+ Booster Capsule Average Price by Company (2021-2026)
  5. 3.5 Global NAD+ Booster Capsule Company Ranking (2024-2026)
  6. 3.6 Global NAD+ Booster Capsule Company Manufacturing Base and Headquarters
  7. 3.7 Global NAD+ Booster Capsule Company Product Type and Application
  8. 3.8 Global NAD+ Booster Capsule Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global NAD+ Booster Capsule Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 NAD+ Booster Capsule Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 NAD+ Booster Capsule Market by Type
  1. 4.1 NAD+ Booster Capsule Type Introduction
  2. 4.1.1 Content ＜98%
  3. 4.1.2 Content ≥98%
  4. 4.2 Global NAD+ Booster Capsule Sales Volume by Type
  5. 4.2.1 Global NAD+ Booster Capsule Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global NAD+ Booster Capsule Sales Volume by Type (2021-2032)
  7. 4.2.3 Global NAD+ Booster Capsule Sales Volume Share by Type (2021-2032)
  8. 4.3 Global NAD+ Booster Capsule Sales Value by Type
  9. 4.3.1 Global NAD+ Booster Capsule Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global NAD+ Booster Capsule Sales Value by Type (2021-2032)
  11. 4.3.3 Global NAD+ Booster Capsule Sales Value Share by Type (2021-2032)
5 NAD+ Booster Capsule Market by Application
  1. 5.1 NAD+ Booster Capsule Application Introduction
  2. 5.1.1 Health Care Products
  3. 5.1.2 Beauty Products
  4. 5.1.3 Others
  5. 5.2 Global NAD+ Booster Capsule Sales Volume by Application
  6. 5.2.1 Global NAD+ Booster Capsule Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global NAD+ Booster Capsule Sales Volume by Application (2021-2032)
  8. 5.2.3 Global NAD+ Booster Capsule Sales Volume Share by Application (2021-2032)
  9. 5.3 Global NAD+ Booster Capsule Sales Value by Application
  10. 5.3.1 Global NAD+ Booster Capsule Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global NAD+ Booster Capsule Sales Value by Application (2021-2032)
  12. 5.3.3 Global NAD+ Booster Capsule Sales Value Share by Application (2021-2032)
6 NAD+ Booster Capsule Regional Sales and Value Analysis
  1. 6.1 Global NAD+ Booster Capsule Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global NAD+ Booster Capsule Sales by Region (2021-2032)
  3. 6.2.1 Global NAD+ Booster Capsule Sales by Region: 2021-2026
  4. 6.2.2 Global NAD+ Booster Capsule Sales by Region (2027-2032)
  5. 6.3 Global NAD+ Booster Capsule Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global NAD+ Booster Capsule Sales Value by Region (2021-2032)
  7. 6.4.1 Global NAD+ Booster Capsule Sales Value by Region: 2021-2026
  8. 6.4.2 Global NAD+ Booster Capsule Sales Value by Region (2027-2032)
  9. 6.5 Global NAD+ Booster Capsule Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America NAD+ Booster Capsule Sales Value (2021-2032)
  12. 6.6.2 North America NAD+ Booster Capsule Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe NAD+ Booster Capsule Sales Value (2021-2032)
  15. 6.7.2 Europe NAD+ Booster Capsule Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific NAD+ Booster Capsule Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific NAD+ Booster Capsule Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America NAD+ Booster Capsule Sales Value (2021-2032)
  21. 6.9.2 South America NAD+ Booster Capsule Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa NAD+ Booster Capsule Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa NAD+ Booster Capsule Sales Value Share by Country, 2025 VS 2032
7 NAD+ Booster Capsule Country-level Sales and Value Analysis
  1. 7.1 Global NAD+ Booster Capsule Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global NAD+ Booster Capsule Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global NAD+ Booster Capsule Sales by Country (2021-2032)
  4. 7.3.1 Global NAD+ Booster Capsule Sales by Country (2021-2026)
  5. 7.3.2 Global NAD+ Booster Capsule Sales by Country (2027-2032)
  6. 7.4 Global NAD+ Booster Capsule Sales Value by Country (2021-2032)
  7. 7.4.1 Global NAD+ Booster Capsule Sales Value by Country (2021-2026)
  8. 7.4.2 Global NAD+ Booster Capsule Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA NAD+ Booster Capsule Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA NAD+ Booster Capsule Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA NAD+ Booster Capsule Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada NAD+ Booster Capsule Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada NAD+ Booster Capsule Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada NAD+ Booster Capsule Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico NAD+ Booster Capsule Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico NAD+ Booster Capsule Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico NAD+ Booster Capsule Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany NAD+ Booster Capsule Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany NAD+ Booster Capsule Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany NAD+ Booster Capsule Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France NAD+ Booster Capsule Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France NAD+ Booster Capsule Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France NAD+ Booster Capsule Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. NAD+ Booster Capsule Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. NAD+ Booster Capsule Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. NAD+ Booster Capsule Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy NAD+ Booster Capsule Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy NAD+ Booster Capsule Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy NAD+ Booster Capsule Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain NAD+ Booster Capsule Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain NAD+ Booster Capsule Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain NAD+ Booster Capsule Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia NAD+ Booster Capsule Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia NAD+ Booster Capsule Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia NAD+ Booster Capsule Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands NAD+ Booster Capsule Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands NAD+ Booster Capsule Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands NAD+ Booster Capsule Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries NAD+ Booster Capsule Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries NAD+ Booster Capsule Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries NAD+ Booster Capsule Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China NAD+ Booster Capsule Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China NAD+ Booster Capsule Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China NAD+ Booster Capsule Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan NAD+ Booster Capsule Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan NAD+ Booster Capsule Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan NAD+ Booster Capsule Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea NAD+ Booster Capsule Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea NAD+ Booster Capsule Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea NAD+ Booster Capsule Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India NAD+ Booster Capsule Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India NAD+ Booster Capsule Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India NAD+ Booster Capsule Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia NAD+ Booster Capsule Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia NAD+ Booster Capsule Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia NAD+ Booster Capsule Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia NAD+ Booster Capsule Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia NAD+ Booster Capsule Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia NAD+ Booster Capsule Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil NAD+ Booster Capsule Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil NAD+ Booster Capsule Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil NAD+ Booster Capsule Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina NAD+ Booster Capsule Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina NAD+ Booster Capsule Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina NAD+ Booster Capsule Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile NAD+ Booster Capsule Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile NAD+ Booster Capsule Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile NAD+ Booster Capsule Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia NAD+ Booster Capsule Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia NAD+ Booster Capsule Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia NAD+ Booster Capsule Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru NAD+ Booster Capsule Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru NAD+ Booster Capsule Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru NAD+ Booster Capsule Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia NAD+ Booster Capsule Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia NAD+ Booster Capsule Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia NAD+ Booster Capsule Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel NAD+ Booster Capsule Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel NAD+ Booster Capsule Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel NAD+ Booster Capsule Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE NAD+ Booster Capsule Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE NAD+ Booster Capsule Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE NAD+ Booster Capsule Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey NAD+ Booster Capsule Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey NAD+ Booster Capsule Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey NAD+ Booster Capsule Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran NAD+ Booster Capsule Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran NAD+ Booster Capsule Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran NAD+ Booster Capsule Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt NAD+ Booster Capsule Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt NAD+ Booster Capsule Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt NAD+ Booster Capsule Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 EffePharm
  2. 8.1.1 EffePharm Company Information
  3. 8.1.2 EffePharm Business Overview
  4. 8.1.3 EffePharm NAD+ Booster Capsule Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 EffePharm NAD+ Booster Capsule Product Portfolio
  6. 8.1.5 EffePharm Recent Developments
  7. 8.2 Kingdomway
  8. 8.2.1 Kingdomway Company Information
  9. 8.2.2 Kingdomway Business Overview
  10. 8.2.3 Kingdomway NAD+ Booster Capsule Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Kingdomway NAD+ Booster Capsule Product Portfolio
  12. 8.2.5 Kingdomway Recent Developments
  13. 8.3 GeneHarbor
  14. 8.3.1 GeneHarbor Company Information
  15. 8.3.2 GeneHarbor Business Overview
  16. 8.3.3 GeneHarbor NAD+ Booster Capsule Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 GeneHarbor NAD+ Booster Capsule Product Portfolio
  18. 8.3.5 GeneHarbor Recent Developments
  19. 8.4 Bontac
  20. 8.4.1 Bontac Company Information
  21. 8.4.2 Bontac Business Overview
  22. 8.4.3 Bontac NAD+ Booster Capsule Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Bontac NAD+ Booster Capsule Product Portfolio
  24. 8.4.5 Bontac Recent Developments
  25. 8.5 NOMON Co., Ltd. (Teijin)
  26. 8.5.1 NOMON Co., Ltd. (Teijin) Company Information
  27. 8.5.2 NOMON Co., Ltd. (Teijin) Business Overview
  28. 8.5.3 NOMON Co., Ltd. (Teijin) NAD+ Booster Capsule Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 NOMON Co., Ltd. (Teijin) NAD+ Booster Capsule Product Portfolio
  30. 8.5.5 NOMON Co., Ltd. (Teijin) Recent Developments
  31. 8.6 Mirailab Bioscience Inc. (Shinkowa Pharmaceutical)
  32. 8.6.1 Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) Company Information
  33. 8.6.2 Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) Business Overview
  34. 8.6.3 Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) NAD+ Booster Capsule Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) NAD+ Booster Capsule Product Portfolio
  36. 8.6.5 Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) Recent Developments
  37. 8.7 Maac10 Formulas
  38. 8.7.1 Maac10 Formulas Company Information
  39. 8.7.2 Maac10 Formulas Business Overview
  40. 8.7.3 Maac10 Formulas NAD+ Booster Capsule Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Maac10 Formulas NAD+ Booster Capsule Product Portfolio
  42. 8.7.5 Maac10 Formulas Recent Developments
  43. 8.8 Herbalmax
  44. 8.8.1 Herbalmax Company Information
  45. 8.8.2 Herbalmax Business Overview
  46. 8.8.3 Herbalmax NAD+ Booster Capsule Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Herbalmax NAD+ Booster Capsule Product Portfolio
  48. 8.8.5 Herbalmax Recent Developments
  49. 8.9 Genex Formulas
  50. 8.9.1 Genex Formulas Company Information
  51. 8.9.2 Genex Formulas Business Overview
  52. 8.9.3 Genex Formulas NAD+ Booster Capsule Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Genex Formulas NAD+ Booster Capsule Product Portfolio
  54. 8.9.5 Genex Formulas Recent Developments
  55. 8.10 EZZ
  56. 8.10.1 EZZ Company Information
  57. 8.10.2 EZZ Business Overview
  58. 8.10.3 EZZ NAD+ Booster Capsule Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 EZZ NAD+ Booster Capsule Product Portfolio
  60. 8.10.5 EZZ Recent Developments
  61. 8.11 Elysium Health
  62. 8.11.1 Elysium Health Company Information
  63. 8.11.2 Elysium Health Business Overview
  64. 8.11.3 Elysium Health NAD+ Booster Capsule Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Elysium Health NAD+ Booster Capsule Product Portfolio
  66. 8.11.5 Elysium Health Recent Developments
  67. 8.12 Chromadex
  68. 8.12.1 Chromadex Company Information
  69. 8.12.2 Chromadex Business Overview
  70. 8.12.3 Chromadex NAD+ Booster Capsule Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Chromadex NAD+ Booster Capsule Product Portfolio
  72. 8.12.5 Chromadex Recent Developments
  73. 8.13 CELFULL
  74. 8.13.1 CELFULL Company Information
  75. 8.13.2 CELFULL Business Overview
  76. 8.13.3 CELFULL NAD+ Booster Capsule Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 CELFULL NAD+ Booster Capsule Product Portfolio
  78. 8.13.5 CELFULL Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 NAD+ Booster Capsule Value Chain Analysis
  2. 9.1.1 NAD+ Booster Capsule Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 NAD+ Booster Capsule Sales Mode & Process
  6. 9.2 NAD+ Booster Capsule Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 NAD+ Booster Capsule Distributors
  9. 9.2.3 NAD+ Booster Capsule Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst